A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 14,448 shares of NVS stock, worth $1.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,448
Previous 12,901 11.99%
Holding current value
$1.5 Million
Previous $1.37 Million 20.98%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$106.13 - $120.89 $164,183 - $187,016
1,547 Added 11.99%
14,448 $1.66 Million
Q2 2024

Jul 11, 2024

SELL
$92.57 - $107.37 $7.83 Million - $9.08 Million
-84,592 Reduced 86.77%
12,901 $1.37 Million
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $162,054 - $184,507
-1,701 Reduced 1.71%
97,493 $9.43 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $205,393 - $226,028
2,226 Added 2.3%
99,194 $10 Million
Q3 2023

Oct 19, 2023

BUY
$94.73 - $105.13 $73,699 - $81,791
778 Added 0.81%
96,968 $9.88 Million
Q2 2023

Aug 04, 2023

SELL
$92.52 - $104.91 $333,072 - $377,676
-3,600 Reduced 3.61%
96,190 $9.71 Million
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $412,634 - $478,528
5,156 Added 5.45%
99,790 $9.18 Million
Q4 2022

Feb 03, 2023

SELL
$75.55 - $92.52 $1.45 Million - $1.77 Million
-19,163 Reduced 16.84%
94,634 $8.59 Million
Q3 2022

Nov 01, 2022

BUY
$74.61 - $87.26 $119,749 - $140,052
1,605 Added 1.43%
113,797 $8.65 Million
Q2 2022

Aug 12, 2022

BUY
$80.52 - $93.75 $323,126 - $376,218
4,013 Added 3.71%
112,192 $9.48 Million
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $1.41 Million - $1.6 Million
17,645 Added 19.49%
108,179 $9.49 Million
Q4 2021

Jan 21, 2022

SELL
$79.7 - $88.13 $399,456 - $441,707
-5,012 Reduced 5.25%
90,534 $7.92 Million
Q3 2021

Nov 01, 2021

BUY
$81.78 - $95.14 $7.81 Million - $9.09 Million
95,546 New
95,546 $7.81 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.